Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers

Condition:   Asthma
Interventions:   Drug: Seretide 250(8puffs) via Evohaler actuator;   Drug: Seretide 250 (8 puffs)/placebo via Volumatic spacer;   Drug: Seretide 250/placebo 8 puffs via Aerochamber Plus spacer;   Drug: Seretide 250/placebo via Synchro-Breathe
Sponsor:   University of Dundee
Completed – verified December 2009

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Leave a Reply

Your email address will not be published. Required fields are marked *